- COVID-19 and cancer: reflections 2 years into the pandemic
-
Saba K, Dhawaria M, Javed A
- KMID: 2562787
- Korean J Clin Oncol.
- 2024 Dec;20(2):47-50.
- doi: 10.14216/kjco.24008
The COVID-19 pandemic, which emerged in the light of day toward the end of 2019, has changed almost every field of health care basically, and oncology is no exception. After... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of stromal tumor-infiltrating lymphocytes with clinicopathological parameters in endometrial cancer
-
Ahuja S, Dubey A, Zaheer S
- KMID: 2562789
- Korean J Clin Oncol.
- 2024 Dec;20(2):74-78.
- doi: 10.14216/kjco.24010
Purpose: Endometrial cancer (EC) ranks as one of the most prevalent gynecological malignancies globally. The presence and role of stromal tumor-infiltrating lymphocytes (TILs) in the tumor microenvironment have garnered interest... -
- CITED
-
- Close
- SHARE
-
- Close
- The unseen spread–Schnitzler’s metastasis unveiled: a case report
-
Ayyamperumal JA, Chandrabose Ambedkar MJ, Lakshmanan A, Satyanesan J
- KMID: 2562792
- Korean J Clin Oncol.
- 2024 Dec;20(2):88-92.
- doi: 10.14216/kjco.24013
Metastasis to the rectum is very rare and is usually caused by primaries from the breast, gastrointestinal tract, and genitourinary system. We report here a case of acute intestinal obstruction... -
- CITED
-
- Close
- SHARE
-
- Close
- The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives
-
Ahuja S, Zaheer S
- KMID: 2562788
- Korean J Clin Oncol.
- 2024 Dec;20(2):51-73.
- doi: 10.14216/kjco.24009
Cancer immunotherapy uses the body’s immune system to combat cancer, marking a significant advancement in treatment. This review traces its evolution from the late 19th century to its current status.... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term tumor suppression in cholangiocarcinoma using cytokine-induced killer cell therapy and high-dose vitamin C: a case report
-
Kim K, Wang H, Lee J, Yeom C
- KMID: 2562791
- Korean J Clin Oncol.
- 2024 Dec;20(2):84-87.
- doi: 10.14216/kjco.24012
This case study explores the effectiveness of autologous cytokine-induced killer (CIK) cell-based immunotherapy in a 49-year-old male patient with inoperable stage IIIb cholangiocarcinoma, characterized by high levels of the sodium-dependent... -
- CITED
-
- Close
- SHARE
-
- Close
- Exploring the clinicopathological parameters of HER2 low breast cancers: insights from a retrospective cohort study
-
Ahuja S, Khan AA, G K, Zaheer S
- KMID: 2562790
- Korean J Clin Oncol.
- 2024 Dec;20(2):79-83.
- doi: 10.14216/kjco.24011
Purpose: Breast cancer subtypes are delineated by human epidermal growth factor receptor 2 (HER2) expression, pivotal in treatment selection. HER2-positive tumors typically respond to targeted therapies, whereas HER2-negative tumors lack... -
- CITED
-
- Close
- SHARE
-
- Close
